论文部分内容阅读
2001年6月20日美国食品药品管理局(FDA)发布公告,要求在全美国范围内收回已售出的13种中成药,因为这些中成药可能危害民众健康。 FDA警告全国消费者不要继续使用含有马兜铃酸的中药材及中成药,因为该成分可能对消费者的健康造成损伤。马兜铃酸含于某些植物中,有一定的肾膜
On June 20, 2001, the United States Food and Drug Administration (FDA) issued an announcement requiring the recall of 13 proprietary Chinese medicines sold throughout the United States, because these Chinese patent medicines may endanger public health. The FDA warns consumers across the country not to continue using Chinese herbal medicines and proprietary Chinese medicines containing aristolochic acid because the ingredients may cause damage to consumers’ health. Aristolochic acid is contained in certain plants and has a certain degree of kidney membrane